Spago Nanomedical AB Statistics

Total Valuation

FRA:7UX has a market cap or net worth of EUR 7.87 million. The enterprise value is 5.09 million.

Market Cap	7.87M
Enterprise Value	5.09M

Important Dates

The last earnings date was Monday, February 2, 2026.

Earnings Date	Feb 2, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	661.57M
Shares Outstanding	n/a
Shares Change (YoY)	+26.88%
Shares Change (QoQ)	+30.33%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	424.27M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	17.66
PB Ratio	2.77
P/TBV Ratio	2.77
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-2.07
EV / Sales	11.27
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 6.96

Current Ratio	6.96
Quick Ratio	5.77
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -83.01% and return on invested capital (ROIC) is -52.64%.

Return on Equity (ROE)	-83.01%
Return on Assets (ROA)	-44.16%
Return on Invested Capital (ROIC)	-52.64%
Return on Capital Employed (ROCE)	-85.49%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	63,652
Profits Per Employee	-350,524
Employee Count	7
Asset Turnover	0.13
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -39.29% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-39.29%
50-Day Moving Average	0.01
200-Day Moving Average	0.02
Relative Strength Index (RSI)	52.52
Average Volume (20 Days)	n/a

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, FRA:7UX had revenue of EUR 445,566 and -2.45 million in losses. Loss per share was -0.01.

Revenue	445,566
Gross Profit	-615,310
Operating Income	-2.49M
Pretax Income	-2.45M
Net Income	-2.45M
EBITDA	-2.47M
EBIT	-2.49M
Loss Per Share	-0.01

Full Income Statement

Balance Sheet

The company has 2.74 million in cash and n/a in debt, with a net cash position of 2.74 million.

Cash & Cash Equivalents	2.74M
Total Debt	n/a
Net Cash	2.74M
Net Cash Per Share	n/a
Equity (Book Value)	2.84M
Book Value Per Share	0.00
Working Capital	2.84M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-2.61M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	-138.10%
Operating Margin	-558.77%
Pretax Margin	-550.68%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

FRA:7UX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-26.88%
Shareholder Yield	-26.88%
Earnings Yield	-31.18%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1